School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Antimicrob Agents Chemother. 2012 Sep;56(9):4703-6. doi: 10.1128/AAC.00848-12. Epub 2012 Jun 18.
The treatment of infections caused by antibiotic-resistant bacteria is one of the great challenges faced by clinicians in the 21st century. Antibiotic resistance genes are often transferred between bacteria by mobile genetic vectors called plasmids. It is commonly believed that removal of antibiotic pressure will reduce the numbers of antibiotic-resistant bacteria due to the perception that carriage of resistance imposes a fitness cost on the bacterium. This study investigated the ability of the plasmid pCT, a globally distributed plasmid that carries an extended-spectrum-β-lactamase (ESBL) resistance gene (bla(CTX-M-14)), to persist and disseminate in the absence of antibiotic pressure. We investigated key attributes in plasmid success, including conjugation frequencies, bacterial-host growth rates, ability to cause infection, and impact on the fitness of host strains. We also determined the contribution of the bla(CTX-M-14) gene itself to the biology of the plasmid and host bacterium. Carriage of pCT was found to impose no detectable fitness cost on various bacterial hosts. An absence of antibiotic pressure and inactivation of the antibiotic resistance gene also had no effect on plasmid persistence, conjugation frequency, or bacterial-host biology. In conclusion, plasmids such as pCT have evolved to impose little impact on host strains. Therefore, the persistence of antibiotic resistance genes and their vectors is to be expected in the absence of antibiotic selective pressure regardless of antibiotic stewardship. Other means to reduce plasmid stability are needed to prevent the persistence of these vectors and the antibiotic resistance genes they carry.
抗生素耐药菌引起的感染的治疗是 21 世纪临床医生面临的重大挑战之一。抗生素耐药基因通常通过称为质粒的移动遗传载体在细菌之间转移。人们普遍认为,由于携带耐药性会给细菌带来适应性成本,因此去除抗生素压力将减少抗生素耐药菌的数量。本研究调查了质粒 pCT 的能力,该质粒广泛分布,携带一种扩展谱β-内酰胺酶(ESBL)耐药基因(bla(CTX-M-14)),在没有抗生素压力的情况下,它能够持续存在和传播。我们研究了质粒成功的关键属性,包括接合频率、细菌宿主生长速度、引起感染的能力以及对宿主菌株适应性的影响。我们还确定了 bla(CTX-M-14)基因本身对质粒和宿主细菌生物学的贡献。携带 pCT 不会给各种细菌宿主带来可检测到的适应性成本。缺乏抗生素压力和抗生素耐药基因的失活对质粒的持久性、接合频率或细菌-宿主生物学也没有影响。总之,像 pCT 这样的质粒已经进化到对宿主菌株的影响很小。因此,无论抗生素管理如何,在没有抗生素选择压力的情况下,抗生素耐药基因及其载体的持续存在是可以预期的。需要采取其他手段来降低质粒的稳定性,以防止这些载体及其携带的抗生素耐药基因的持续存在。